Companies: 10,795·Total market cap: $144.5T
Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZBOTCHealthcare
$0.70
$-0.00(-0.16%)
Market Cap$36587801
P/E Ratio—
52W High$1.19
52W Low$0.252
Overview

Enzo Biochem, Inc. (ENZB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000316253 · ENZB · OTC · as of Jun 9, 2026

Filing snapshot

1,010+
Total Filings
SCHEDULE 13G/A
Latest Form
2025-11-14
Most Recent
1980
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000316253 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-10-29
Fiscal Year End
Oct 29, 2024
Accession No.
0001213900-24-091798
Primary Document
ea0218602-10k_enzobio.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000316253 · Accession 0001213900-24-091798

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2025-06-16
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2025-08-20Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-14
View
EFFECTEFFECT
EFFECT
2025-08-29
View
EFFECTEFFECT
EFFECT
2025-08-29
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-08-22
View
15-12G15-12G
FORM 15-12G
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
S-8 POSS-8 POS
POST-EFFECTIVE AMENDMENT NO TO FORM S-8
2025-08-20
View
Showing 1–15 of 735 filingsForm 4 / 144 hidden· 1010 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000316253  |  Exchange: OTC · Healthcare

Enzo Biochem, Inc. (OTC: ENZB) has submitted 1,010+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1980. As a Healthcare sector company with CIK 0000316253, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Enzo Biochem, Inc.'s most comprehensive regulatory disclosure. The most recent Enzo Biochem, Inc. 10-K was filed on 2024-10-29 for fiscal year ending 2024. Historical ENZB 10-K annual reports are available from 2005 through 2024.

Investors researching Enzo Biochem, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MDPEF SEC Filings →DMTTF SEC Filings →TREIF SEC Filings →CSWYY SEC Filings →ACOGF SEC Filings →PMXSF SEC Filings →IGXT SEC Filings →MKEAF SEC Filings →
→ ENZB Financials→ ENZB Earnings→ ENZB Insider Trades

Frequently Asked Questions

ENZB SEC Filings · 8 questions

Enzo Biochem, Inc. (ENZB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,010+ filings and access original documents at no cost. Enzo Biochem, Inc.'s CIK is 0000316253.

ENZB SEC filingsEnzo Biochem, Inc. SEC documentsfind ENZB 10-K